Assessing risk in pulmonary arterial hypertension: what we know, what we don't

Raymond L Benza¹, Harrison W Farber², Mona Selej^{3

4}, Mardi Gomberg-Maitland⁵

Affiliations

¹ Cardiovascular Medicine, Allegheny General Hospital, Pittsburgh, PA, USA RBENZA@wpahs.org.
² Pulmonary and Critical Care, Boston Medical Center, Boston, MA, USA.
³ University of California San Francisco, Dept of Medicine, Cardiology, Pulmonary Hypertension Clinic, San Francisco, CA, USA.
⁴ Actelion Pharmaceuticals US, Inc., South San Francisco, CA, USA.
⁵ Cardiology, Heart and Vascular Institute, Falls Church, VA, USA.

PMID: 28775053
DOI: 10.1183/13993003.01353-2017

Free article

Editorial

Assessing risk in pulmonary arterial hypertension: what we know, what we don't

Raymond L Benza et al. Eur Respir J. 2017.

Free article

. 2017 Aug 3;50(2):1701353.

doi: 10.1183/13993003.01353-2017. Print 2017 Aug.

Authors

Raymond L Benza¹, Harrison W Farber², Mona Selej^{3

4}, Mardi Gomberg-Maitland⁵

Affiliations

¹ Cardiovascular Medicine, Allegheny General Hospital, Pittsburgh, PA, USA RBENZA@wpahs.org.
² Pulmonary and Critical Care, Boston Medical Center, Boston, MA, USA.
³ University of California San Francisco, Dept of Medicine, Cardiology, Pulmonary Hypertension Clinic, San Francisco, CA, USA.
⁴ Actelion Pharmaceuticals US, Inc., South San Francisco, CA, USA.
⁵ Cardiology, Heart and Vascular Institute, Falls Church, VA, USA.

PMID: 28775053
DOI: 10.1183/13993003.01353-2017

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Comment on

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
Kylhammar D, Kjellström B, Hjalmarsson C, Jansson K, Nisell M, Söderberg S, Wikström G, Rådegran G. Kylhammar D, et al. Eur Heart J. 2018 Dec 14;39(47):4175-4181. doi: 10.1093/eurheartj/ehx257. Eur Heart J. 2018. PMID: 28575277
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, Olsson KM, Meyer K, Vizza CD, Vonk-Noordegraaf A, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Huscher D, Pittrow D, Rosenkranz S, Grünig E. Hoeper MM, et al. Eur Respir J. 2017 Aug 3;50(2):1700740. doi: 10.1183/13993003.00740-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28775047
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O. Boucly A, et al. Eur Respir J. 2017 Aug 3;50(2):1700889. doi: 10.1183/13993003.00889-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28775050

References

1. Circulation. 2014 Jan 7;129(1):57-65 - PubMed
1. Eur Respir J. 2012 Sep;40(3):530-2 - PubMed
1. Chest. 2015 Feb;147(2):484-494 - PubMed
1. BMJ. 2015 Aug 11;351:h3868 - PubMed
1. Eur Respir J. 2017 Aug 3;50(2):null - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Assessing risk in pulmonary arterial hypertension: what we know, what we don't

Affiliations

Assessing risk in pulmonary arterial hypertension: what we know, what we don't

Authors

Affiliations

Conflict of interest statement

Comment on

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical